Health & Wellness Blog - Page 54

Telangana DCA Warns Against Unsupervised Semaglutide Use Amid Weight Loss Demand

The Telangana Drugs Control Administration (DCA) has issued a strong warning against unsupervised use of semaglutide, a popular GLP-1 drug for weight loss and Type-2 diabetes management. With generics now available from Sun Pharma, Dr. Reddy's, Zydus, and Glenmark following patent expiry, demand is surging—but so are risks like acute pancreatitis and kidney injury. Always consult a doctor for proper assessment and prescription.

Shotlee·Mar 24, 2026·5 min read

GLP-1 Medications

GLP-1 Drugs Surge: Healthy Habits Still Essential for Best Results

Demand for GLP-1 drugs like Wegovy and Zepbound is booming, with 1 in 8 Americans now using them. But experts warn: medication alone isn't enough—pairing with healthy habits like protein-rich meals, exercise, and sleep amplifies weight loss and health gains, per recent studies.

Shotlee·Mar 24, 2026·6 min read

GLP-1 Medications

Alkem Launches Affordable Semaglutide Injection in India at Rs450 Weekly

Alkem Laboratories is revolutionizing GLP-1 access in India with its new semaglutide injection, priced at just Rs450 per week. Branded as Semasize, Obesema, and Hepaglide, this once-weekly therapy targets Type 2 diabetes and chronic weight management. Learn about its approvals, innovative pens, and potential impact on affordable care.

Shotlee·Mar 24, 2026·5 min read

Nutrition & GLP-1 Therapy

What Does a GLP-1 Friendly Diet Look Like? Nutritionists Explain

As GLP-1 drugs like Wegovy and Zepbound surge in popularity, food companies are slapping 'GLP-1 Friendly' labels on products. But nutritionists warn these may mislead—true GLP-1 diets emphasize protein, fiber, and planning to combat side effects and sustain weight loss.

Shotlee·Mar 23, 2026·5 min read

Weight Loss & Metabolic Health

Python Blood Molecule May Unlock Healthy Weight Loss Secrets

Scientists have uncovered a satiety-signaling molecule in python blood that surges dramatically after meals, potentially paving the way for healthier weight loss without the nausea common in drugs like Ozempic. This discovery from pythons' feast-and-fast metabolism highlights a new biological pathway involving gut bacteria. Could pTOS be the key to natural appetite control?

Shotlee·Mar 23, 2026·5 min read

GLP-1 Business & Telehealth

Hims & Hers Stock: Costly Wegovy Deal Challenges

Hims & Hers has resolved its dispute with Novo Nordisk, shifting to official weight loss drugs like Wegovy over controversial compounded GLP-1 alternatives. This brings legal clarity but slams profitability with higher costs and a cautious Q1 2026 revenue outlook of $600-625 million. With 2.5 million subscribers, can the stock rebound amid debt and investigations?

Shotlee·Mar 23, 2026·4 min read

GLP-1 Medications

Semaglutide Prices Drop 70-90% in India After Generic Launches by Sun Pharma,...

Semaglutide prices in India have plummeted by up to 90% following the launch of over 15 generic versions just days after patent expiry. Major players like Sun Pharma, Zydus Lifesciences, Dr Reddy's, and Natco are offering affordable options for type 2 diabetes and obesity management. This shift promises greater access to this vital GLP-1 agonist therapy.

Shotlee·Mar 23, 2026·6 min read

GLP-1 Medications

Study: 10% of Wegovy and Ozempic Users See Minimal Weight Loss

Recent trials show about 10% of people using Wegovy and Ozempic experience minimal weight loss, classified as 'non-responders.' Despite average reductions of 15-20%, stories like Samantha Jess's highlight real challenges. Discover why GLP-1 drugs don't work for everyone and how to optimize results.

Shotlee·Mar 23, 2026·5 min read

GLP-1 Medications

Grim Effects of Stopping GLP-1s Like Ozempic, Study Finds

New research paints a stark picture: stopping GLP-1 drugs like Ozempic can rapidly reverse cardiovascular benefits, with risks spiking 8% after just six months. Published in BMJ Medicine, the study tracked over 333,000 adults and warns of 'metabolic whiplash.' Patients face weight regain, inflammation resurgence, and lasting scars from interruptions.

Shotlee·Mar 23, 2026·4 min read

Latest Articles

Latest Articles

Telangana DCA Warns Against Unsupervised Semaglutide Use Amid Weight Loss Demand

GLP-1 Drugs Surge: Healthy Habits Still Essential for Best Results

Alkem Launches Affordable Semaglutide Injection in India at Rs450 Weekly

What Does a GLP-1 Friendly Diet Look Like? Nutritionists Explain

Python Blood Molecule May Unlock Healthy Weight Loss Secrets

Hims & Hers Stock: Costly Wegovy Deal Challenges

Semaglutide Prices Drop 70-90% in India After Generic Launches by Sun Pharma,...

Study: 10% of Wegovy and Ozempic Users See Minimal Weight Loss

Grim Effects of Stopping GLP-1s Like Ozempic, Study Finds

Latest Articles

Telangana DCA Warns Against Unsupervised Semaglutide Use Amid Weight Loss Demand

GLP-1 Drugs Surge: Healthy Habits Still Essential for Best Results

Alkem Launches Affordable Semaglutide Injection in India at Rs450 Weekly

What Does a GLP-1 Friendly Diet Look Like? Nutritionists Explain

Python Blood Molecule May Unlock Healthy Weight Loss Secrets

Hims & Hers Stock: Costly Wegovy Deal Challenges

Semaglutide Prices Drop 70-90% in India After Generic Launches by Sun Pharma,...

Study: 10% of Wegovy and Ozempic Users See Minimal Weight Loss

Grim Effects of Stopping GLP-1s Like Ozempic, Study Finds